e-learning
resources
ERJ
2004
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia
Abdalla S.A., Gallione C.J., Barst R.J., Horn E.M., Knowles J.A., Marchuk D.A., Letarte M., Morse J.H.
Source:
Eur Respir J 2004; 23: 373-377
Journal Issue:
March
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Abdalla S.A., Gallione C.J., Barst R.J., Horn E.M., Knowles J.A., Marchuk D.A., Letarte M., Morse J.H.. Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia. Eur Respir J 2004; 23: 373-377
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
The pulmonary vascular complications of hereditary haemorrhagic telangiectasia
Source: Eur Respir J 2009; 33: 1186-1194
Year: 2009
Endoglin germline mutation, hereditary hemorrhagic telangiectasia and fenfluramine-associated pulmonary arterial hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 463s
Year: 2003
Prevalence of pulmonary hypertension in a large cohort of patients with hereditary hemorrhagic telangiectasia
Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights
Year: 2015
Pulmonary hypertension in hereditary hemorrhagic telangiectasia is associated with multiple clinical conditions
Source: International Congress 2019 – Pulmonary hypertension: clinical
Year: 2019
Pulmonary hypertension in hereditary haemorrhagic telangiectasia is associated with multiple clinical conditions
Source: ERJ Open Res, 7 (1) 00078-2020; 10.1183/23120541.00078-2020
Year: 2021
Severe pulmonary hypertension after the discovery of the familial primary pulmonary hypertension gene
Source: Eur Respir J 2001; 17: 1065-1069
Year: 2001
TBX4 syndrome: a systemic disease highlighted by pulmonary arterial hypertension in its most severe form
Source: Eur Respir J, 55 (5) 2000585; 10.1183/13993003.00585-2020
Year: 2020
Genetics of pulmonary hypertension: from bench to bedside
Source: Eur Respir J 2002; 20: 741-749
Year: 2002
Pulmonary hypertension in children
Source: Eur Respir Mon 2012; 57: 94-107
Year: 2012
Fatal rupture of pulmonary arteriovenous malformation in hereditary haemorrhagic telangiectasis and severe PAH
Source: Eur Respir Rev 2009; 18: 42-46
Year: 2009
Portopulmonary hypertension: a further clue to pathogenesis?
Source: Annual Congress 2005 - Challenges in the biological understanding of pulmonary arterial hypertension
Year: 2005
Ortner‘s syndrome associated with secondary pulmonary hypertension
Source: Eur Respir J 2004; 24: Suppl. 48, 55s
Year: 2004
Familial pulmonary arterial hypertension by
KDR
heterozygous loss of function
Source: Eur Respir J, 55 (4) 1902165; 10.1183/13993003.02165-2019
Year: 2020
Should we screen for hereditary pulmonary hypertension?
Source: Virtual Congress 2020 – Don't blame your parents: causes of pulmonary hypertension in early life
Year: 2020
Pulmonary arterial hypertension in scleroderma – manifestation of systemic endothelial dysfunction
Source: Eur Respir J 2006; 28: Suppl. 50, 548s
Year: 2006
Tadalafil in idiopathic or heritable pulmonary arterial hypertension compared to pulmonary arterial hypertension associated with connective tissue disease
Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Year: 2011
The Role of Inflammation in promoting pulmonary hypertension in idiopatchi and connective tissue disease-associated PAH
Source: Research Seminar 2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept